Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia

References

• Hamblin T J, Davis Z, Gardiner A, Oscier D G, Stevenson F K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854
   PubMed Web of Science ®Google Scholar
• Damle R N, Wasil T, Fais F, Ghiotto F, Valetto A, Allen S L, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847
   PubMed Web of Science ®Google Scholar
• Durig J, Nuckel H, Cremer M, Führer A, Halfmeyer K, Fandrey J, et al. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia 2003; 17: 2426–2434
   PubMed Web of Science ®Google Scholar
• Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1764–1775
   PubMed Web of Science ®Google Scholar
• Orchard J A, Ibbotson R E, Davis Z, Wiestner A, Rosenwald A, Thomas P W, et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004; 363: 105–111
   PubMed Web of Science ®Google Scholar
• Catherwood M A, Matthews C, Niblock R, Dobbin E, Morris T C, Alexander H D. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia. Eur J Haematol 2006; 76: 294–298
   PubMed Web of Science ®Google Scholar
• Hayat A, O'Brien D, O'Rourke P, McGuckin S, Fitzgerald T, Conneally E, et al. CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia. Leuk Lymphoma 2006; 47: 2371–2379
   PubMed Web of Science ®Google Scholar
• Krober A, Seiler T, Benner A, Bullinger L, Brückle E, Lichter P, et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002; 100: 1410–1416
   PubMed Web of Science ®Google Scholar
• Oppezzo P, Vasconcelos Y, Settegrana C, Jeannel D, Vuillier F, Legarff-Tavernier M, et al. The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood 2005; 106: 650–657
   PubMed Web of Science ®Google Scholar
• Buhl A M, Jurlander J, Jørgensen F S, Ottesen A M, Cowland J B, Gjerdrum L M, et al. Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia. Blood 2006; 107: 2904–2911
   PubMed Web of Science ®Google Scholar
• Tobin G. The immunoglobulin genes and chronic lymphocytic leukemia (CLL). Ups J Med Sci 2005; 110: 97–113
   PubMed Web of Science ®Google Scholar
• Tobin G, Soderberg O, Thunberg U, Rosenquist R. V(H)3-21 gene usage in chronic lymphocytic leukemia – characterization of a new subgroup with distinct molecular features and poor survival. Leuk Lymphoma 2004; 45: 221–228
   PubMed Web of Science ®Google Scholar
• Matthews C, Catherwood M A, Morris T C, Alexander H D. V(H)3-48 and V(H)3-53, as well as V(H)3-21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosis. Leuk Res 2007; 31: 231–234
   PubMed Web of Science ®Google Scholar
• Guarini A, Gaidano G, Mauro F R, Capello D, Mancini F, De Propris M S, et al. Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood 2003; 102: 1035–1041
   PubMed Web of Science ®Google Scholar
• Capello D, Guarini A, Berra E, Mauro F R, Rossi D, Ghia E, et al. Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia. Leukemia 2004; 8: 1941–1947
   Web of Science ®Google Scholar
• Capello D, Zucchetto A, Degan M, Bomben R, Dal Bo M, Efremov D G, et al. Immunophenotypic characterization of IgVH3-72 B-cell chronic lymphocytic leukaemia (B-CLL). Leuk Res 2006; 30: 1197–1199
   PubMed Web of Science ®Google Scholar
• Tobin G, Thunberg U, Karlsson K, Murray F, Laurell A, Willander K, et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004; 104: 2879–2885
   PubMed Web of Science ®Google Scholar
• Widhopf GF I I, Rassenti L Z, Toy T L, Gribben J G, Wierda W G, Kipps T J. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 2004; 104: 2499–2504
   PubMed Web of Science ®Google Scholar
• Messmer B T, Albesiano E, Efremov D G, Ghiotto F, Allen S L, Kolitz J, et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004; 200: 519–525
   PubMed Web of Science ®Google Scholar
• Murray F, Darzentas N, Hadzidimitriou A, Tobin G, Boudjogra M, Scielzo C, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008; 21: 2537–2538
   Google Scholar
• Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood 2007; 109: 259–270
   PubMed Web of Science ®Google Scholar
• Walewska R, Majid A, Davis Z, Dusanjh P, Kennedy D B, Oscier D G, et al. Male preponderance in chronic lymphocytic leukaemia utilizing IgHV 1-69. Leukemia 2007; 21: 2537–2538
   PubMed Web of Science ®Google Scholar
• Mauerer K, Zahrieh D, Gorgun G, Li A, Zhou J, Ansén S, et al. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia. Br J Haematol 2005; 129: 499–510
   PubMed Web of Science ®Google Scholar
• Kienle D, Benner A, Krober A, Winkler D, Mertens D, Bühler A, et al. Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes. Blood 2006; 107: 2090–2093
   PubMed Web of Science ®Google Scholar
• Panovska-Stavridis I, Ivanovski M, Siljanovski N, Cevreska L, Efremov D G. Chronic lymphocytic leukemia patients with a V1-69 gene rearrangement do not have inferior survival with respect to patients that express other unmutated V(H) genes. Leuk Res 2007; 31: 245–248
   PubMed Web of Science ®Google Scholar
• Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen S L, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998; 102: 1515–1525
   PubMed Web of Science ®Google Scholar
• van Dongen J J, Langerak A W, Bruggemann M, Evans P A, Hummel M, Lavender F L, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257–2317
   PubMed Web of Science ®Google Scholar
• Ghia P, Belessi C, Daví F, Rosenquist R, Stamatopoulos K. Reply to ‘Male preponderance in chronic lymphocytic leukaemia utilizing IgHV 1-69. Leukemia 2007;21:2539 – 2540
   Google Scholar
• Duke V M, Gandini D, Sherrington P D, Lin K, Heelan B, Amlot P, et al. V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Haematologica 2003; 88: 1259–1271
   PubMed Web of Science ®Google Scholar
• Potter K N, Orchard J, Critchley E, Mockridge C I, Jose A, Stevenson F K. Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire. Blood 2003; 101: 3082–3084
   PubMed Web of Science ®Google Scholar
• Marasca R, Vaccari P, Luppi M, Zucchini P, Castelli I, Barozzi P, et al. Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol 2001; 159: 253–261
   PubMed Web of Science ®Google Scholar